Bioinformatics Suppliers In Europe

For more than 40 years, Agilent Technologies has been the leading provider of solutions for the detection, identification, and characterization of chemical and biological compounds. From environmental testing to semiconductor manufacturing, ...

If you deal with large amounts of data and samples, Agilent SLIMS increases your lab's productivity, eases the process of sample management, and helps you reduce errors. Our core competences are professional open source and integration (LIMS) ...

Hummingbird is harnessing the predictive power of blood-borne miRNAs to provide insights into human health and disease. Analysis of miRNAs with Hummingbird’s platform holds the potential for early disease detection, disease-specific prognostics, ...

Pluristem Therapeutics Inc. is a clinical-stage regenerative medicine company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, muscle injuries, ...

The privately held small enterprise SeqOmics Biotechnology Ltd. was founded by established scientists in order to provide solutions for the permanently increasing demand for genomics and bioinformatics services, as well as food safety and animal ...

SeqOne Genomics is a startup based in Montpellier in the South of France, founded in 2017. The company develops state-of-the-art genomics analysis tools for clinical applications in the fields of cancer and rare diseases. Its flagship product, ...

Vaiomer microbiome studies and expert service supports your discoveries and innovations when identifying predictors and mechanisms associated with the development of chronic diseases. Vaiomer challenges the frontiers of microbiome research by ...

At Alithea Genomics we are committed to developing solutions that simplify and streamline the generation of 'big RNA data', which we believe will constitute the foundation of tomorrow's research and medicine. Our technologies enable our clients to ...

GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and chronic liver diseases. Our translational disease-driven research approach is based on strong expertise, featuring in-house knowledge of ...

Diatech Pharmacogenetics is the Italian leader in the development, production and commercialisation of pharmacogenetics tests for cancer precision medicine. Founded in 1996, Diatech Pharmacogenetics has sustained constant organic growth over the ...

Founded in 2016 by a group of experienced engineers and bio-informaticians under the leadership of Claudio Alberti, our CTO, GenomSys is a Swiss company developing state-of-the-art technology and services for the efficient analysis and secure ...

Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists ...

Seven Bridges is the leading biomedical data company, specializing in software and data analytics to drive public and private healthcare research. We deliver end-to-end bioinformatic solutions including access to datasets, analytic workflows and ...

Biogemma is a European plant biotechnology company founded in 1997 by seed companies and French field crop producers. Its original mission was to create new genetic variability via GM traits to be exploited by its shareholding companies. With the ...

Harmonizing Science & Data to Create a Better Future, Together. From developing new personalized and preventive patient treatment solutions to revising climate change - Dotmatics solutions are at the core of scientific innovation. At Dotmatics, we ...

The technological progress made in biomedical research has radically changed the view to new treatment strategies. Modern genetic technologies can deliver disease-relevant targets but are insufficient to refill the empty drug discovery pipeline. We ...

The microbiome's most powerful innovation platform. Unlocking radical innovation by enabling the conversation between microbiome data and the scientist. The microbiome's most powerful innovation platform. Unlocking radical innovation by enabling the ...

We are a passionate and skilled drug discovery and development biotech team developing an innovative new class of oligonucleotide antimicrobial agents. Procarta is currently working on lead optimisation for its first product, a narrow-spectrum agent ...

Core members of Cambridge Protein Arrays' team have been leading protein microarray development and application since the beginning of the field. As a dedicated protein array company, we build on this expertise, making it available for the projects ...